Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
21
Number of overlapping holdings
70.0%
% of PJP's 30 holdings also in XPH
51.2%
% of XPH's 41 holdings also in PJP
Overlap by Weight
Sector Drift (PJP minus XPH)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PJP | Weight in XPH | Overlap | |
|---|---|---|---|---|
 |
JOHNSON & JOHNSON | 5.1% | 3.7% | 3.7% |
|
ELI LILLY & CO | 4.7% | 3.7% | 3.7% |
|
PFIZER INC | 4.9% | 3.6% | 3.6% |
|
MERCK & CO. INC. | 5.0% | 3.5% | 3.5% |
|
TARSUS PHARMACEUTICALS, INC. | 3.5% | 3.9% | 3.5% |
Position Highlights (Non-Overlapping Exposures)
PJP Overweight Relative to XPH
|
ABBVIE INC | 5.2% |
|
GILEAD SCIENCES INC | 5.2% |
|
AMGEN INC | 5.0% |
|
ABBOTT LABORATORIES | 5.0% |
|
BIOGEN IDEC INC | 2.7% |
|
TRAVERE THERAPEUTICS, INC. | 2.7% |
|
REGENERON PHARMACEUTICALS | 2.5% |
|
UNITED THERAPEUTICS CORP | 2.4% |
|
GERON CORP | 2.0% |
|
BIOSANTE PHARMACEUTICALS INC | 1.6% |
PJP Underweight Relative to XPH
|
ZOETIS INC | -3.7% |
|
INTRA-CELLULAR THERAPIES INC | -3.7% |
|
ELANCO ANIMAL HEALTH, INC. | -3.7% |
|
AXSOME THERAPEUTICS, INC. | -3.7% |
|
ORGANON & CO. | -3.6% |
|
ROYALTY PHARMA PLC CLASS A | -3.5% |
|
EDGEWISE THERAPEUTICS, INC. | -3.2% |
|
ARVINAS, INC. | -2.2% |
|
HARROW INC | -1.8% |
|
VIATRIS, INC. | -1.4% |